JPRN-UMIN000013186招募中未知
Multicenter study of serum HER2 monitoring in tissue HER2 positive gastric cancer - Evaluation of serum HER2 in tissue HER2 positive gastric cancer
Gastroenterologic Surgery, Kanazawa University0 个研究点目标入组 30 人开始时间: 2014年2月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with other active cancers 2. Patients with uncontrolled or severe complications
研究者
相似试验
已完成
不适用
Observational study of serum HER2 in HER2 positive advanced gastric cancer treated with trastuzumab in combination with capecitabine plus cisplatin(XP+H)Gastric cancerJPRN-UMIN000006445Sapporo Medical University 1st department of Internal Medicine10
进行中（未招募）
1 期
DetectIV - Treatment of patients with advanced metastatic breast cancer and circulating blood cells devoid of Her2/neu.EUCTR2013-001269-18-DEniversitätsklinikum Ulm (AöR)300
已完成
不适用
Observational study of Serum HER2 in HER2 negative advanced gastric cancer treated with capecitabine plus cisplatin(XP)Gastric cancerJPRN-UMIN000006442Sapporo Medical University 1st department of Internal Medicine50
已完成
不适用
Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology SamplesBreast CancerNCT02580799Hoffmann-La Roche30
已完成
不适用
Observational study of HER2 positive rate in advanced or recurrent gastric cancerAdvanced or recurrent gastric cancerJPRN-UMIN000006190Japanese Foundation for Multidisciplinary Treatment of Cancer1,200